AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2012
Mar 26, 2012
30826_dirs_2012-03-26_f5f233ef-748a-4b55-b7d5-a4e2e14c1496.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2012-03-22
Reporting Person: RUSCHE JAMES R (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-22 | Common Stock | M | 25000 | $3.24 | Acquired | 158874 | Direct |
| 2012-03-22 | Common Stock | F | 16233 | $4.99 | Disposed | 142641 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-22 | Stock Option (Right to Buy) | $3.24 | M | 25000 | Disposed | 2012-04-11 | Common Stock (25000) | Direct |
Footnotes
F1: Payment made via forfeiture of 16,233 shares of Common Stock valued at the Closing Price of $4.99 on March 22, 2012.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23